Fromkin Andrew J.

Insider profile

Fromkin Andrew J.'s trades of Immunovant Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-29 2026-05-28 S Sale
8,731 -26.4%
349.34
US$4,742,091
8,731 -26.4% 349.34 US$4,742,091
2026-05-29 2026-05-28 S Sale
5,847 -35.9%
90.99
US$3,191,444
5,847 -35.9% 90.99 US$3,191,444
2026-05-28 2026-05-28 PrS Proposed sale
24,719
12.16
US$1,943,844
24,719 12.16 US$1,943,844
2025-12-03 2025-12-01 PlS Planned sale
2,898 -3.3%
23.95
US$69,407
2,898 -3.3% 23.95 US$69,407
2025-12-03 2025-12-01 PlS Planned sale
19,351 -17.9%
23.14
US$447,782
19,351 -17.9% 23.14 US$447,782
2025-12-01 2025-12-01 PrS Proposed sale
22,249
24.15
US$537,313
22,249 24.15 US$537,313
2025-03-11 2025-03-07 PlS Planned sale
1,384 -1.5%
19.96
US$27,625
1,384 -1.5% 19.96 US$27,625
2025-03-11 2025-03-07 PlS Planned sale
6,616 -6.6%
19.52
US$129,144
6,616 -6.6% 19.52 US$129,144
2025-03-07 2025-03-07 PrS Proposed sale
8,000
19.52
US$156,160
8,000 19.52 US$156,160
2023-12-05 2023-12-01 PlS Planned sale
4,773 -5.1%
40.46
US$193,116
4,773 -5.1% 40.46 US$193,116
2023-12-05 2023-12-01 PlS Planned sale
3,636 -3.7%
39.81
US$144,749
3,636 -3.7% 39.81 US$144,749
2023-12-05 2023-12-01 PlS Planned sale
3,941 -3.9%
38.78
US$152,832
3,941 -3.9% 38.78 US$152,832
2023-12-01 2023-12-01 PrS Proposed sale
12,350
39.13
US$483,256
12,350 39.13 US$483,256